Effect of Q10 supplementation on body weight and body mass index: A systematic review and meta-analysis of randomized controlled clinical trials.


Journal

Diabetes & metabolic syndrome
ISSN: 1878-0334
Titre abrégé: Diabetes Metab Syndr
Pays: Netherlands
ID NLM: 101462250

Informations de publication

Date de publication:
Historique:
received: 09 01 2019
accepted: 23 01 2019
entrez: 25 7 2019
pubmed: 25 7 2019
medline: 28 12 2019
Statut: ppublish

Résumé

This meta-analysis study was carried out to assess the effects of coenzyme Q10 supplementation on body weight and body mass index of patients in randomized controlled clinical trial studies. A comprehensive systematic search of literature was performed through ISI web of sciences, PubMed, Scopus and Cochrane library databases up to February 2018 which was supplemented by manual search of the references list of included studies. From a total of 1579 identified articles, only 17 trials with 14 and 14 effect-sizes were included for pooling the effects of co-enzyme Q10 supplementation on body weight and body mass index, respectively. Results of random-effect size meta-analysis showed that supplementation with coenzyme Q10 had no significant decreasing effects on body weight (WMD: 0.28 kg; 95% CI = -0.91, 1.47; P = 0.64) and BMI (WMD: -0.03; 95% CI = -0.4, 0.34; P = 0.86) of study participants. Subgroup analysis revealed that dosage of Q10 and trial duration could not differ the results of Q10 supplementation. Results of this meta-analysis study failed to show any beneficial effect of coenzyme Q10 supplementation on body weight and BMI of patients in clinical trial studies.

Identifiants

pubmed: 31336462
pii: S1871-4021(19)30016-5
doi: 10.1016/j.dsx.2019.01.047
pii:
doi:

Substances chimiques

Ubiquinone 1339-63-5
coenzyme Q10 EJ27X76M46

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1179-1185

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Somayeh Saboori (S)

Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.

Esmaeil Yousefi Rad (EY)

Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.

Mahnaz Mardani (M)

Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.

Mohammad Zeinali Khosroshahi (MZ)

Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran.

Yasaman Nouri (Y)

Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran.

Ebrahim Falahi (E)

Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. Electronic address: falahi.e@lums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH